Cellid, Co., Ltd. - ROE
299660.KQ
Price:
$1758
Market Cap:
$51.87B
Cellid, a South Korean firm established in 2006, specializes in creating immunotherapeutic vaccines designed to combat various cancers and infectious ailments. Their pipeline includes BVAC-C, which targets cervical, head and neck, anal, and genital cancers linked to the human papillomavirus (HPV) antigen. They are also advancing BVAC-B for gastric, ovarian, lung, and pancreatic cancers, focusing on the HER-2/neu antigen, and BVAC-P, intended for prostate, urinary tract, and brain cancers by leveraging PAP/PSMA antigens. Furthermore, Cellid is working on BVAC-M for melanoma and other cancers, utilizing GP100/MAGE-A3 antigens, alongside BVAC-Neo, a personalized immunotherapeutic vaccine soluti...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2019-02-19
Stock Exchange
KOE
Ticker
299660.KQ
PE Ratio
[-0.99]
ROE
[-39.22%]
Current Ratio
[0.57]
Dividend Yield
[0%]
Enterprise Value
[72.63B]
Dividend History
The ROE as of August 2026 (TTM) for Cellid, Co., Ltd. (299660.KQ) is -39.22%
According to Cellid, Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -39.22%. This represents a change of 236.88% compared to the average of -11.64% of the last 4 quarters.
Cellid, Co., Ltd. (299660.KQ) Historical ROE (quarterly & annually)
How has 299660.KQ ROE performed in the past?
The mean historical ROE of Cellid, Co., Ltd. over the last ten years is 65.68%. The current -39.22% ROE has changed -159.71% with respect to the historical average. Over the past ten years (40 quarters), 299660.KQ's ROE was at its highest in in the March 2017 quarter at 607.37%. The ROE was at its lowest in in the December 2022 quarter at -44.27%.
Average
65.68%
Median
-20.10%
Minimum
-101.90%
Maximum
860.71%
Cellid, Co., Ltd. (299660.KQ) ROE by Quarter and Year
Discovering the peaks and valleys of Cellid, Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 286.54%
Maximum Annual ROE = 860.71%
Minimum Annual Increase = -835.52%
Minimum Annual ROE = -101.90%
| Year | ROE | Change |
|---|---|---|
| 2025 | -16.26% | -32.07% |
| 2024 | -23.94% | -16.50% |
| 2023 | -28.67% | -71.86% |
| 2022 | -101.90% | 202.18% |
| 2021 | -33.72% | 286.54% |
| 2020 | -8.72% | 79.58% |
| 2019 | -4.86% | -94.19% |
| 2018 | -83.63% | -185.47% |
| 2017 | 97.84% | -88.63% |
| 2016 | 860.71% | -835.52% |
Cellid, Co., Ltd. (299660.KQ) Average ROE
How has 299660.KQ ROE performed in the past?
The current ROE of Cellid, Co., Ltd. (299660.KQ) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-22.96%
5-year avg
-40.90%
10-year avg
65.68%
Cellid, Co., Ltd. (299660.KQ) ROE vs. Peers
How is 299660.KQ’s ROE compared to its peers?
Cellid, Co., Ltd.’s ROE is greater than Sugentech Inc. (-30.23%), less than P&S Robotics Co., Ltd. (5.27%), less than Ildong Holdings Co., Ltd. (13.43%), greater than Oncocross Co., Ltd. (-64.01%), greater than Aprogen Biologics Inc. (-36.87%), greater than iNtRON Biotechnology, Inc. (-15.73%), less than Hyundai Pharmaceutical Co., Ltd. (4.19%), less than CG Invites Co., Ltd. (0.47%), less than DongKook Life Science (0%), less than Shinhung Co., Ltd (4.64%),
| Company | ROE | Market cap |
|---|---|---|
| -30.23% | $60.01B | |
| 5.27% | $68.76B | |
| 13.43% | $73.74B | |
| -64.01% | $40.73B | |
| -36.87% | $25.30B | |
| -15.73% | $84.80B | |
| 4.19% | $137.18B | |
| 0.47% | $61.52B | |
| 0% | $70.37B | |
| 4.64% | $130.60B |
Build a custom stock screener for Cellid, Co., Ltd. (299660.KQ) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellid, Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Cellid, Co., Ltd. (299660.KQ) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Cellid, Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Cellid, Co., Ltd.'s ROE?
How is the ROE calculated for Cellid, Co., Ltd. (299660.KQ)?
What is the highest ROE for Cellid, Co., Ltd. (299660.KQ)?
What is the 3-year average ROE for Cellid, Co., Ltd. (299660.KQ)?
What is the 5-year average ROE for Cellid, Co., Ltd. (299660.KQ)?
How does the current ROE for Cellid, Co., Ltd. (299660.KQ) compare to its historical average?